Showing results (41-50 of 190) with videos related to
Sort By:
Pageof 19
Drugs|November 22, 2014
The biology and clinical development of MEK inhibitors for cancerJason J Luke, Patrick A Ott, Geoffrey I ShapiroFrontiers in Immunology|April 19, 2021
High Throughput Multi-Omics Approaches for Clinical Trial Evaluation and Drug DiscoveryJessica M Zielinski, Jason J Luke, Silvia Guglietta, et al.Journal for Immunotherapy of Cancer|June 23, 2016
Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trialJason J Luke, Yuanyuan Zha, Karen Matijevich, et al.Cancer Immunology Research|September 6, 2018
T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy SelectionJonathan A Trujillo, Randy F Sweis, Riyue Bao, et al.Nature Reviews. Clinical Oncology|April 5, 2017
Targeted agents and immunotherapies: optimizing outcomes in melanomaJason J Luke, Keith T Flaherty, Antoni Ribas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2024
Facts and Hopes in Using Omics to Advance Combined Immunotherapy StrategiesRyan C Augustin, Wesley L Cai, Jason J Luke, et al.Nature Reviews. Clinical Oncology|April 26, 2022
Optimal systemic therapy for high-risk resectable melanomaAlexander M M Eggermont, Omid Hamid, Georgia V Long, et al.International Journal of Breast Cancer|June 5, 2018
The Evolution of Radiation Therapy in Metastatic Breast Cancer: From Local Therapy to Systemic AgentJessica M S Jutzy, Jeffrey M Lemons, Jason J Luke, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 8, 2019
Facial Palsy Induced by Checkpoint Blockade: A Single Center Retrospective StudyCarlen Yuen, Pankti Reid, Zuoli Zhang, et al.Cancers|June 2, 2021
STING Agonists as Cancer TherapeuticsAfsaneh Amouzegar, Manoj Chelvanambi, Jessica N Filderman, et al.Pageof 19